Price to Cash Flow ratio Analysis of Pfizer Inc - Deep Dive


Latest FY Price to CF
Period Ending - Dec-24

11.07


Good Price to CF
Period Ending - Dec-23
16.16

Indecisive Price to CF
Growth
-31.48 %
Most recent Quarter Price to CF
Period Ending - Jun-25

-242.75


Very Poor Price to CF
Price to CF Analysis of Pfizer Inc
Price to CF Ratio of PFE drastically fell by -31.48 % this year.
Price to CF Ratio with value of 16.16 was highest in Year Dec-23 in last Five Years.
Price to CF Ratio with value of 4.27 was lowest in Year Dec-21 in last Five Years.
Latest Price to CF Ratio with value of 11.07 is Greater than Average Price to CF of 9.17 in last five years.
Other Price to CF Related Info of PFE that may interest you.
Pfizer Inc Overview
CodePricePrevious PricePrice ChangeSector
PFE24.7624.670.365 % Drug Manufacturers-General
Fundamental AnalysisTechnical Analysis
Defination of Price to Cash Flow
The Price-to-Cash Flow from Operation ratio compares the company's stock price with its operating cash flow per share. Cash flow can't be easily manipulated compared to earnings, which is the importance of this ratio. This ratio indicates how much investors are willing to pay for each rupee of operating cash generated by the company.   more ..
Price to Cash Flow Formula

Price to CF Related Ratios
PriceToSalesRatioFreeCashflowToRevenuePriceToEarningRatio

Tsr Value Index
Good Value
FY - Historical Price to Cash Flow of Pfizer Inc
PeriodDec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18
Price to CF11.0716.164.754.279.5910.989.35
Change-31.48 %240.03 %11.32 %-55.48 %-12.66 %17.44 %2.67 %
You are view first 7 Records. Log in to view all 40 in Premium view
FY Chart of Price to Cash Flow of Pfizer Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)